Celldex Therapeutics, Inc. (CLDX)

39.68USD +0.79% (+0.31)

Over 1M: -4.9%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

40 42 44
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 1.5M Q3 '23 — Operating Income: -41.2M Q3 '23 — Operating Cash Flow: -19M Q3 '23 — Free Cash Flow: -19.1M Q3 '23 — Net Income: -38.3M Q4 '23 — Revenue: 4.1M Q4 '23 — Operating Income: -47.6M Q4 '23 — Operating Cash Flow: -32.5M Q4 '23 — Free Cash Flow: -33.2M Q4 '23 — Net Income: -43.3M Q1 '24 — Revenue: 156K Q1 '24 — Operating Income: -40.6M Q1 '24 — Operating Cash Flow: -40.6M Q1 '24 — Free Cash Flow: -41M Q1 '24 — Net Income: -32.8M Q2 '24 — Revenue: 2.5M Q2 '24 — Operating Income: -46.3M Q2 '24 — Operating Cash Flow: -29.3M Q2 '24 — Free Cash Flow: -29.6M Q2 '24 — Net Income: -35.8M Q3 '24 — Revenue: 3.2M Q3 '24 — Operating Income: -52.1M Q3 '24 — Operating Cash Flow: -55.3M Q3 '24 — Free Cash Flow: -55.9M Q3 '24 — Net Income: -42.1M Q4 '24 — Revenue: 1.2M Q4 '24 — Operating Income: -56M Q4 '24 — Operating Cash Flow: -32.5M Q4 '24 — Free Cash Flow: -33.2M Q4 '24 — Net Income: -47.1M Q1 '25 — Revenue: 695K Q1 '25 — Operating Income: -62.7M Q1 '25 — Operating Cash Flow: -54.4M Q1 '25 — Free Cash Flow: -54.6M Q1 '25 — Net Income: -53.8M Q2 '25 — Revenue: 730K Q2 '25 — Operating Income: -63.9M Q2 '25 — Operating Cash Flow: -44M Q2 '25 — Free Cash Flow: -44.7M Q2 '25 — Net Income: -56.6M Q3 '25 — Revenue: 0 Q3 '25 — Operating Income: -73.6M Q3 '25 — Operating Cash Flow: -48.6M Q3 '25 — Free Cash Flow: -49.1M Q3 '25 — Net Income: -67M Q4 '25 — Revenue: 121K Q4 '25 — Operating Income: -87.2M Q4 '25 — Operating Cash Flow: -63.9M Q4 '25 — Free Cash Flow: -65.2M Q4 '25 — Net Income: -81.3M Q1 '26 — Revenue: 15K Q1 '26 — Operating Income: -84.4M Q1 '26 — Operating Cash Flow: -65.6M Q1 '26 — Free Cash Flow: -67.2M Q1 '26 — Net Income: -78.7M Q2 '26 — Revenue: 22K Q2 '26 — Operating Income: -80.6M Q2 '26 — Operating Cash Flow: -57.4M Q2 '26 — Free Cash Flow: -60.6M Q2 '26 — Net Income: -73.5M -80M -60M -40M -20M 0 20M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Income Operating Cash Flow Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
Accruals -8.3%
Asset turnover 0.0002×
ROA -38.4%
ROCE -45.2%
ROE -42.1%
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —
SBC / sales —

0 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 15180.2×
EV/OE -8.7×
P/C 4.3×
P/B 4.4×
FCF yield -7.8%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.8
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.8
Current ratio 11.8×
ND/EBITDA 0.3
Cash runway 3.0 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 11.8×
F-score 1.1 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales CAGR 4Y -24.1%
Sales/sh Y/Y -97.4%
Sales Q/Q -97.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.